Paired Antibodies for Progesterone: Three Pitfalls of a 314 Da Competitive Immunoassay
Why Small Molecules Force a Different Assay Design
Progesterone is small, carries only one antigenic determinant, and therefore cannot support a sandwich format. Competitive immunoassay is the only route. That format shifts the burden onto raw materials. If antibody affinity or specificity falls slightly short, the whole calibration curve collapses. The sections below gather the quantification requirements, the technical difficulties of the competitive format, and the parameters of one recombinant monoclonal antibody for reference.
What Progesterone Is and Where It Acts
Progesterone is a C-21 steroid hormone synthesized mainly by the corpus luteum and the placenta. It is a fundamental regulator of the female reproductive system and of embryonic development. Its single most important action is converting the endometrium from the proliferative phase to the secretory phase. That conversion turns the uterine cavity into an environment where an embryo can implant and be maintained. Without it, implantation failure and luteal phase deficiency are almost inevitable.
Synthesis and metabolism follow the classical steroid pathway. Blood concentration swings widely with both the menstrual cycle and the stage of pregnancy. It moves from the low values of the follicular phase to levels that multiply during gestation. This dynamic behavior rules out single-point sampling. A value has to be read together with the sampling time, and that time should be recorded alongside every result. The same patient can produce very different values a week apart.
Three Clinical Judgments That Depend on the Number
Quantifying serum progesterone serves three diagnostic purposes. The first is assessing ovarian function, which includes confirming that ovulation occurred and diagnosing luteal phase defects associated with infertility. The second is monitoring the viability of early pregnancy and providing prognostic information. The third is supporting the differential diagnosis of early pregnancy, where the assay helps separate a viable intrauterine pregnancy from an ectopic pregnancy and from an inevitable miscarriage. All three rest on one precondition: the reagent must measure serum progesterone accurately.
A related review notes that an Expert Consensus on Clinical Applications of Female Reproductive Endocrine Hormone Testing (2022 edition) lists progesterone (PROG) as a core specific indicator. It is used to assess ovulatory function, luteal status, and early pregnancy viability, and to help differentiate abnormal pregnancies. For the precise wording and scope, the original consensus document should be consulted.
Pitfall One: No Sandwich Format Is Available
A small-molecule hapten cannot be measured by two-antibody sandwiching, and the reason is structural. Progesterone is only about 314 Da, and the surface it presents to an antibody offers a single epitope. Simultaneous binding by two antibodies is practically impossible. In practice, progesterone must compete with labeled tracer for a limited number of antibody binding sites, so signal runs inversely with concentration. The curve shape looks nothing like a sandwich curve, and a mismatched affinity blurs the low-concentration range into an unreadable smear.
Pitfall Two: Cross-Reactivity Across the Steroid Family
Specificity is the second trap. Members of the steroid hormone family are structurally very similar. If molecules such as 17-hydroxyprogesterone, cortisol, or testosterone are recognized alongside the target, results drift systematically high. When evaluating this class of antibody, the cross-reactivity rate is worth establishing before sensitivity. It determines whether a low-concentration sample can be trusted to indicate ovulation at all. Absolute cross-reactivity values should be read against the working assay range rather than in isolation.
Pitfall Three: Batch-to-Batch Consistency
The third trap lies in raw material consistency. Competitive formats tolerate inter-batch drift poorly. Any shift in antibody concentration, purity, or buffer composition shows up directly on the standard curve. When screening raw materials, the purification method and the purity criterion deserve priority. The product page for this antibody specifies Protein G purification, greater than 95 percent purity by SEC-HPLC, and a concentration of 2 mg/ml. Those three numbers carry more weight than promotional language. Matrix effects from biological fluids and the traceability chain of the calibrator should be validated at the same time, during method establishment.
A Reference Reagent for Competitive Formats
ANT BIO PTE. LTD. supplies Progesterone Recombinant mAb (SDT-5508) under catalog number S0B3769. The target antigen is progesterone, with molecular aliases progestin, luteohormone, and luteal hormone. Stated applications are competitive ELISA, ELISA, and CLIA. This places the reagent on competitive immunoassay platforms, making it suitable as a starting material for raw material screening and kit development.
| Product Name | Catalog No. | Format & Purity | Applications |
|---|---|---|---|
| Progesterone Recombinant mAb (SDT-5508) | S0B3769 | Recombinant mAb, IgG; Protein G purified, 2 mg/ml, >95% by SEC-HPLC; unconjugated, PBS pH 7.4 with 0.09% sodium azide | Competitive ELISA, ELISA, CLIA |
Reactivity is listed as human, sizes are 0.5 mg and 1 mg, and storage runs 12 months from receipt at 2 to 8 degrees Celsius. One documentation detail is worth flagging: the specification table writes the clone as SDT-05508 while the product name shows SDT-5508. The accompanying datasheet should be treated as authoritative. No independent validation image is provided for this catalog number, so no experimental figure is reproduced here.
On the platform side, the supplier describes recombinant monoclonal antibodies and ready-to-use kits. These have passed matrix screening, linear range validation, recovery testing, and precision analysis. Together they cover antibody pairing compatibility, detection sensitivity, calibrator traceability, and inter-batch stability. Those statements describe platform-level quality control rather than this specific catalog number. Validation data for S0B3769 should be requested from the supplier or read from the datasheet.
Outlook
In small-molecule immunoassay, most of the outcome is decided at the raw material stage. An antibody that documents its purity, concentration, and buffer composition clearly saves considerable rework during method validation. Progesterone is a good test case: the molecule is simple, the clinical stakes are not, and the assay format leaves no margin for a loosely characterized reagent.
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
ANT BIO PTE. LTD. supplies high-quality reagents and solutions for life science research. Our sub-brands cover the full research workflow: Starter for antibodies and immunological assay kits, UA-Bio for recombinant proteins and drug discovery solutions, and Absin for general reagents and other detection kits. Explore our product portfolio at www.antbioinc.com.
Disclaimer
This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.
